Iesa Pharmaceuticals Private Limited
About Iesa Pharmaceuticals Private Limited
Data last updated:
Iesa Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the retail trade segment of the trading and commerce sector. It was incorporated on 30 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U70100UP2014PTC062372. Its GSTIN is 09AAFCG5590F2ZD (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Greenmagic Infra Private Limited. It is led by directors Nasreen Younus and Atiqur Rahman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No 4 Mariyam Plaza Amrapali Mkt, Lucknow, Uttar Pradesh, India – 226016.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.29 Lakh, a growth of 77% compared to the previous year. For the same year it recorded a net profit of ₹6,058 (net margin 0.6%) and EBITDA of ₹34,624 (EBITDA margin 3.4%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹5.85 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Iesa Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 4 Mariyam Plaza Amrapali Mkt, Lucknow, Uttar Pradesh, India – 226016
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Iesa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Iesa Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Iesa Pharmaceuticals Private Limited, buy the company report.
Financials of Iesa Pharmaceuticals Private Limited
FY 2025 filings availableIesa Pharmaceuticals Private Limited reported revenue of ₹10.29 Lakh (up 77% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 77% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 20%. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34,624 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,058 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Iesa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Iesa Pharmaceuticals Private Limited
Iesa Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nasreen Younus | Director | 09 Mar 2020 | 6 Years 7 Months | Current |
| Atiqur Rahman | Director | 30 Jan 2014 | 12 Years 8 Months | Current |
Peer comparison
Iesa Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cosy Pharmaceuticals Private Limited | ₹10.3 Lakh (FY 2025) | -20.0% | Uttar Pradesh, India | |||
| Iesa Pharmaceuticals Private Limitedthis company | ₹10.29 Lakh (FY 2025) | ₹6,058 | 0.6% | 77.0% | Lucknow, Uttar Pradesh, India | |
| Himabhoomi Pharmaceuticals Private Limited | ₹10.27 Lakh (FY 2018) | 22.0% | Hyderabad, Telangana, India | |||
| Flounder Pharmaceuticals Private Limited | ₹10.26 Lakh (FY 2023) | 209.0% | Bareilly, Uttar Pradesh, India | |||
| Wana Pharmaceuticals Private Limited | ₹10.21 Lakh (FY 2021) | Sahibabad, Uttar Pradesh, India |
To see the full peer comparison of Iesa Pharmaceuticals Private Limited, buy the company report.
Auditor
Iesa Pharmaceuticals Private Limited is audited by FNCA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| FNCA & ASSOCIATES | FY 2017 | 018642C |
Shareholding
The shareholding of Iesa Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Iesa Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jun 2020 | 100352586 | Others | ₹85,000 | Open | |
| 29 Dec 2017 | 100149505 | Others | ₹5 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Iesa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Iesa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Iesa Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCG5590F2ZD | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Iesa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Iesa Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Fazlur Rahman ceased to be Director on 16 Jun 2022.
Frequently asked questions
Iesa Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in retailers, within the trading industry. It was incorporated on 30 January 2014 (12+ years old) and is registered under CIN U70100UP2014PTC062372.
Iesa Pharmaceuticals has 2 current directors:
- Nasreen Younus - Director
- Atiqur Rahman - Director
The latest financial statements of Iesa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Iesa Pharmaceuticals is 09AAFCG5590F2ZD, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Iesa Pharmaceuticals is U70100UP2014PTC062372. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Iesa Pharmaceuticals was incorporated on 30 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Iesa Pharmaceuticals by revenue are Cosy Pharmaceuticals Private Limited, Himabhoomi Pharmaceuticals Private Limited, Flounder Pharmaceuticals Private Limited, Wana Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Fazlur Rahman ceased to be Director on 16 Jun 2022. Nasreen Younus was appointed as Director on 09 Mar 2020. Atiqur Rahman was appointed as Director on 30 Jan 2014.
The registered office of Iesa Pharmaceuticals is at Shop No 4 Mariyam Plaza Amrapali Mkt, Lucknow, Uttar Pradesh, India – 226016.
Iesa Pharmaceuticals operates in the trading industry, in the retailers segment.
Iesa Pharmaceuticals has open charges of ₹5.85 Lakh and no satisfied charges on record as per latest MCA filings.